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Abstract 
Background: Malawi launched Option B+ in July 2011, a program for all pregnant or 
breastfeeding HIV-positive women to begin lifelong combination antiretroviral therapy (cART). 
This study characterizes the continuum of care within an antenatal setting in Lilongwe. 
Methods: Women testing HIV-positive at Bwaila Antenatal Clinic from July 2013 to January 
2014 were included. HIV testing and counseling logs were examined, and HIV-infected women 
were linked to HIV mastercards and infant test records. Logistic regression models were used to 
analyze relationships between characteristics recorded on the logs and maternal cART initiation, 
retention, and return for infant testing. 
Results: During this period, 578 women tested HIV-positive. Of these women, 490 (85%) were 
linked to an ART initiation record; of these women, 398 (81%) had at least one follow-up record; 
and of these women, 197 (49%) were retained with full adherence to antiretroviral therapy for 
three months. Two hundred twenty (38%) were linked to a record of infant testing. Women 
without an ART record (aOR = 0.19; 95% CI: 0.10, 0.35), women with no follow-up visits (aOR 
= 0.20; 95% CI: 0.11, 0.36), and women not fully adherent for three months (aOR = 0.56; 95% 
CI: 0.37, 0.84) were less likely to return for infant testing than women who were retained and 
adherent for three months. 
Discussion: Even with a test-and-treat program, many women did not initiate cART, remain in 
care, or bring their infant for testing. Women lost are at highest risk for transmission and were 
least likely to bring infants for testing. Facilitating care-seeking at all steps of the continuum 
remains an important unmet need. Ensuring maternal health has the potential to make major 
contributions towards maintaining environmental health, thus augmenting the importance of this 
research.
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Introduction 
In July 2011, Malawi launched the Option B+ program in an effort to improve prevention 
of mother-to-child transmission of HIV, decrease maternal morbidity and mortality, and prevent 
sexual transmission of HIV. This simple approach calls for all HIV-positive women who are 
pregnant or breastfeeding to start lifelong combination antiretroviral therapy (cART). Previously, 
Malawi’s guidelines had called for cART initiation based on clinical stage or CD4 count, which 
led to lower rates of cART initiation, due to challenges or delays in CD4 testing[1]. The 
initiation of Option B+ precipitated a 748% increase in cART coverage for pregnant women with 
HIV [1]. In the ensuing years, the WHO began recommending Option B+, and many countries in 
the region are introducing this program.  
The long-term success of Option B+ hinges on retaining women in care throughout the 
prevention of mother-to-child transmission of HIV (PMTCT) continuum. Following HIV testing 
at the antenatal clinic, HIV-positive women are given cART and scheduled for a first follow-up 
visit one month later. Women who start Option B+ during pregnancy have five times the odds of 
never returning after their first clinic visit compared to women who start ART based on WHO 
clinical stage and CD4 count guidelines [2]. To maximize the efficacy of Option B+, loss to 
follow-up (LTF) must be reduced because the long-term success of cART requires continuing 
adherence to treatment and care-seeking. Maternal LTF can occur at any point along the PMTCT 
continuum of care, and characterizing the women LTF at each step can facilitate the 
development of targeted interventions. The continuum has not been detailed in depth in a busy 
urban setting, and the factors associated with progressing to each step have not been 
characterized.  
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Early infant diagnosis is essential to determine which infants are HIV-infected and 
require treatment. Approximately one third of HIV-exposed infants in sub-Saharan Africa 
PMTCT programs are lost to follow-up by three months and nearly half are lost after HIV 
testing[3]. In a study using community health workers to facilitate linkage to care, mother-to-
child transmission (MTCT) rates in Lilongwe post-B+ have been documented at 4.1% at first 
PCR test, with an association between maternal cART and reduced transmission[4]. The 
proportion of women retained in treatment through delivery in this setting increased significantly 
from 51.1% to 65% post-B+[4]. Infant retention as well as patient-level data specifically from a 
district hospital in Lilongwe with a mature Option B+ program has not yet been examined. 
Correlates with the progress of women along the continuum of care also merit consideration. 
In this study, we sought to characterize the full PMTCT continuum of care, including the 
prevalence of cART initiation, return for a follow-up visit, retention with full adherence for three 
months, and return for infant testing. We also aim to determine the factors associated with each 
step. We hypothesize that: 1) substantial LTF will occur at each stage along the continuum; 2) 
women who undergo HIV testing and counseling (HTC) with their partners will be lost to 
follow-up at a lower rate than women undergoing individual HTC; 3) women who progress 
further along the continuum of care will be increasingly likely to return for infant testing. 
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Materials and Methods 
Study Setting 
This retrospective cohort study examined records from the antenatal and under-five units 
at Bwaila Hospital in Lilongwe, Malawi. Bwaila is a district-level maternity hospital in 
Lilongwe, Malawi’s capital. The Bwaila Antenatal Clinic (ANC) serves as the initial point of 
contact with these women, and patients. All patients presenting for their first antenatal visit 
without a confirmed HIV test undergo opt-out HTC with rapid tests, in which HTC is offered as 
part of standard treatment but patients can opt-out of receiving that service. Women undergo 
HTC either alone or with a partner. HIV-positive pregnant women were encouraged to initiate 
cART on that day in accordance with Malawi’s Option B+ guidelines[1]. During the study 
period, HTC was not a routine component of subsequent antenatal visits. Women who initiate 
cART are scheduled for an initial follow-up visit in 30 days, with subsequent monthly follow-up 
visits. Women are told to bring their infants back to Bwaila’s Under-Five Clinic for early infant 
diagnosis six weeks after giving birth in order to test the child for HIV. 
Study Population 
The study population consisted of women who tested HIV-positive at their first visit to 
Bwaila ANC during the six-month period from July 19, 2013 to January 18, 2014. HIV-negative 
women were excluded, as were women who had previously initiated cART. 
Data Sources, Abstraction, Linkage 
Nurses record HTC information for women and their partners in the HIV Rapid Testing 
and Counseling Registers (HTC Registers). The HTC Registers also included information about 
visit date, age, HTC access, previous HIV test results, time since last HIV test, the presence of a 
male partner, rapid test results, partner HIV status, and risk category. Antiretroviral Therapy 
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(ART) mastercards contained records of patients’ cART initiation and follow-up, including date 
of ART initiation, birthdate, ART outcome, ART outcome date, and adherence to ART at each 
visit. Early Infant Diagnosis PCR Test Logs contain HIV test results for infants brought back to 
Bwaila ANC at six weeks after birth. Early Infant Diagnosis Logs contained information about 
infant date of birth, reason for HIV testing, HIV test result, cotrimoxazole preventative therapy, 
date of specimen PCR, date the results were received, and date the result was given to the 
patient.  
Data were abstracted from the paper HTC Registers and Early Infant Detection Logs 
from May 20, 2014 to June 20, 2014. A Microsoft Access database was constructed to store the 
information, and data were entered by a trained research assistant. ART mastercard records were 
abstracted on June 18, 2014 from Baobob, the electronic medical records system (EMRS). In 
addition to storing records, the EMRS guides healthcare workers through treatment protocols and 
contains data quality checks. Based on the names and ages of the HIV-positive mothers, as well 
as dates of presentation, a trained research assistant matched records in the HTC Register with 
infant records in the Early Infant Detection Logs and maternal ART mastercards. 
Factors of Interest 
The population of HIV-positive women was characterized on the basis of five-year age 
categories, last HIV test result, time since last HIV test, partner HIV status, and risk category: 
high or low. Time since last HIV test was recorded by providers as less than 24 months, greater 
than or equal to 24 months, or unknown. HTC categories were individual, concordant couple, 
discordant couple, and unknown. Individual HTC involves group pretest counseling with other 
individuals, opt-out testing, individual receipt of results, and individual posttest counseling. 
Couple HTC involves group pretest counseling with other couples, opt-out testing, receipt of 
	   10	  
results as a couple, and partner posttest counseling. When there was insufficient information to 
determine whether a participant who underwent couple HTC was part of a concordant or 
discordant couple, the HTC category of that participant was considered to be unknown. 
Outcomes 
Continuum-related outcomes included the presence of an initial cART initiation record 
(“initiation”), at least one cART follow-up visit (“first follow-up”), and retention in follow-up 
with full adherence for three months (“three-month adherence”). Full adherence was defined 
presentation at three monthly visits with at least 90% adherence at each. The three-month period 
was chosen because almost all women would be expected to have at least three visits before the 
six week infant testing visit based on the typical timing of first visits to the antenatal clinic. The 
presence of an infant HIV PCR testing record in the Early Infant Detection Logs (“infant return”) 
was also examined. 
Analytical Methods 
Unadjusted and adjusted logistic regression models were used to analyze factors of 
interest associated with initiation, first follow-up, three-month retention, and infant return. 
Factors associated with progression to each continuum step were examined only within the group 
of women who had progressed to the previous step, and factors associated with infant return 
were examined for all women studied. Missing data were considered as a separate category in 
each analysis. Analyses were performed using Stata 13.0 (StataCorp). 
A Kaplan-Meier survival curve was constructed to describe retention in care. Survival 
was defined as having initiated cART and having a record of still being alive and on treatment at 
a given time. Women who did not initiate cART were given a treatment failure time of 0 days. 
Women who were lost to follow-up were given a failure time of the day of their last scheduled 
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visit. These women were considered to have defaulted 60 days after their last scheduled follow-
up visit in accordance with national policy. Women who were retained in care were censored on 
the day of their last visit or after twelve months of follow-up. Women who died or stopped 
treatment were given a failure time of the day of the recorded event. For the purpose of 
constructing the graph, 1 month was calculated as 30.417 days. Women who formally transferred 
to another clinic (N=12) were not included in this analysis. 
Ethical Approvals 
These analyses received approval from the University of North Carolina at Chapel Hill 
IRB as well as the Malawian National Health Sciences Research Committee. Because all data 
were routinely collected, the need to obtain informed consent from study subjects was waived. 
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Results 
Between July 19, 2013 and January 18, 2014, 7574 patients were recorded in the HTC 
Registers. Of the patients on record, 6771 were women and 803 were male partners. A total of 
767 women (11%) attended Bwaila ANC with a partner (Table 1). Thirty-six additional men 
were listed in the register without a partner. We assumed that these 36 men brought their 
respective 36 female partners (0.53%) to a follow-up visit at Bwaila ANC. Since those women 
had already visited Bwaila ANC during their pregnancy, their information would not have been 
noted a second time in the HTC registers. 
Overall, 578 women (8.6%) were HIV-positive. As shown in Table 1, 94 women (16%) 
were 15 to 20 years old, 179 women (31%) were 20 to 25 years old, 180 women (31%) were 25 
to 30 years old, and 125 women (22%) were greater than 30 years old.  More than half (325, 
56%) of the women had tested HIV-negative previously, 133 (23%) of the women had 
previously tested HIV-positive, and 120 women (21%) had never been tested for HIV. Of the 
458 women previously tested, 421 (92%) reported the time of their most recent HIV test: 169 
women (29%) had previously been tested within the past 24 months and 252 women (44%) had 
tested more than 24 months ago.  
Nearly all women (n=570, 99%) stated that they had a current partner; 66 of these women 
(12%) came with a male partner on their first visit to Bwaila ANC and received couple HTC. Of 
the women who tested HIV-positive at Bwaila ANC and then received couple’s counseling, 36 
(55%) were concordant HIV-positive, 22 (33%) were discordant (HIV-negative partner), and 8 
(12%) did not know their couple status (Table 1). Though 269 women (46%) did not know their 
partner’s HIV status prior to testing at Bwaila ANC, 190 women (33%) were aware that their 
partner was HIV-negative and 98 women (17%) knew that their partners were HIV-positive. 
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Twenty-six women (5%) described their risk exposure to be high over the past three months, 
while the remaining women classified their risk as low or ongoing. 
Of all HIV-infected women, 490 women (85%) initiated cART, while 88 women (15%) 
did not. Women who underwent HTC as a concordant couple had 0.48 times the odds of 
initiating cART compared to women who underwent individual HTC (Table 2; 95% CI: 0.21, 
1.08). Women who had been tested for HIV less than 24 months ago had 0.43 times the odds of 
initiating compared to women who had never previously tested (95% CI: 0.14, 1.32). The results 
of a woman’s last HIV test and a woman’s age were not associated with the odds of cART 
initiation.  
After initiating cART, 398 initiators (81%) returned for a first follow-up visit. As shown 
in Table 3, there were no precise associations between first follow-up and couple status, last HIV 
test result, time since last HIV test, age, or client risk. Women ages 25-30 had 1.91 times the 
odds of having a first follow-up visit compared to women ages 15-20 (95% CI: 0.89, 4.11). 
Women who underwent HTC as a concordant couple had 3.24 times the odds of having their first 
follow-up visit compared to women who underwent individual HTC (95% CI: 0.73, 14.47). 
Half of the women with a first follow-up visit (N=197; 50%) had three-month adherence. 
Three women (1%) of the 241 women with three follow-up visits did not have all adherence data 
present and were dropped from the analysis. Women who underwent HTC as part of a discordant 
couple had 3.08 times the odds of exhibiting full adherence at their first three follow-up visits 
compared to women who underwent individual HTC (Table 4; 95% CI: 1.02, 9.30). 
Of the 386 initiators (79%) who were retained at 1 month, 353 (91%) were retained for at 
least three months of follow-up, representing 75% of all initiators (Figure 1). Of the women with 
three-month retention, only 197 women (56%) also had three-month adherence. There were 290 
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initiators (59%) who were considered never to have defaulted in accordance with the national 
definition.  
Infant return to Bwaila ANC constitutes the final aspect of the examined continuum of 
care. Based on the Early Infant Detection Logs, 220 women (38%) had an infant record present, 
while 358 women (62%) did not. Compared to women who were retained and adherent for three 
months, non-initiators (aOR=0.19; 95% CI: 0.10, 0.35), non-returners (aOR=0.20; 95% CI: 0.11, 
0.36), and non-adherers (aOR=0.56; 95% CI: 0.37, 0.84) were significantly less likely to exhibit 
infant return (Table 5).  
Among the 220 infants with an infant return record, only two infants tested HIV positive. 
Both infants were born to mothers who had tested HIV negative less than 24 months prior to the 
first test and who underwent individual HTC. The mothers both had partners who they believed 
were HIV negative, and neither reported engaging in high-risk behavior within the past three 
months. One of these mothers had no record of cART initiation, while the other initiated and 
then defaulted after four months of follow-up. She reported perfect adherence at her first visit, 
but did not have perfect adherence throughout the next three months. 
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Discussion 
The vast majority of women who tested HIV-positive at Bwaila ANC could be linked to a 
cART initiation record. Of the women who initiated cART, most returned for a follow-up visit. 
Only half of these women with a follow-up visit were retained with full adherence for three 
months, representing about a third of the total study population. Fewer than half of all women 
who tested HIV-positive returned to Bwaila for infant testing. Women lost at each step of the 
continuum were much less likely to have an infant testing record.  
 To our knowledge, this study is the first to link HTC records to ART records on a patient 
level. Previous investigations conducted throughout Malawi following the initiation of Option 
B+ noted loss up to 24% within the first six months at facilities large enough to use the EMRS, 
with most of this loss occurring within the first three months[2]., We observed a similar retention 
rate, but given that similar retention was observed over only three months, six-month LTF within 
this study population is likely higher. LTF has been noted to vary between 0% and 58% 
depending on the healthcare facility, with urban, Ministry of Health-managed, central hospitals 
using EMRS having the highest proportions of six-month LTF[2]. As a large, urban facility 
managed by the Ministry of Health, Bwaila would be expected to have LTF figures on the upper 
end of the spectrum. HTC practices at Bwaila may be responsible for LTF figures that are lower 
than this literature model predicts. Bwaila ANC nurses emphasize that patients may choose to 
opt out of HIV testing, which may prevent LTF to some extent since perceived coercion into 
receiving an HIV test has been noted as a reason that women in PMTCT programs discontinue 
treatment[5-7].  
We observed lower retention than other studies in Malawi. Overall 12-month Option B+ 
retention within the entire country has been recorded at 77%, and retention in this study falls 
	   16	  
short of that metric even at three months[1]. However, 12-month retention defined by clinic 
attendance alone may not account for missed visits or inconsistent attendance, and these 
measures may have a more significant impact on whether a patient meets the threshold for three-
month retention[8]. Prior to Option B+, women who failed to enroll in PMTCT resulted in the 
greatest loss along the continuum of care[9]. Our study supports the finding that, following the 
introduction of Option B+, LTF enters the continuum of care at later steps but remains 
prevalent[9]. However, considering that proper cART initiation requires at least one follow-up 
visit, a substantial proportion of women still fail to properly start treatment. 
A statistically significant group of women initiate cART, adhere to treatment, and return 
for infant testing. Similar findings have been noted in other parts of sub-Saharan Africa, but 
never in an Option B+ setting or at an urban referral hospital[10-12]. Mothers adherent to a 
cART regimen are more likely to be virally suppressed, which decreases their likelihood of 
transmitting HIV to their child[13]. By engaging in the entire continuum of care, these women 
derive maximum benefit from the Option B+ PMTCT program. This group merits further 
characterization to evaluate causality in order to optimize treatment protocols. 
Healthcare professionals in this setting are likely not seeing the infants at highest risk of 
acquiring HIV. These infants have mothers who are not adherent to cART and who are 
consequently less likely to be virally suppressed. Interventions are needed to engage women who 
do not initiate cART in care beyond antenatal clinic visits. Failure to retain high-risk infants in 
care likely correlates with low rates of infant HIV seropositivity at first PCR test. This is the first 
study in the Option B+ era to examine associations of each step in the continuum with exposed 
infants returning. Additionally, the finding that the same group of women who initiates cART is 
significantly more likely to seek infant testing has not previously been reported.  
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Women may have sought care elsewhere rather than discontinuing care-seeking 
altogether. Formal transfer events were recorded in the EMRS, but they were notably low. 
Informal transfer may have occurred, and this would account for some of the perceived LTF. 
Research indicates that women transfer to other clinics to continue ART more commonly than 
clinic records show, implying that PMTCT retention may be higher than single center data 
suggest[14]. A centralized EMRS, system-wide unique identifier, or a more thorough system of 
recording transfers would be required to evaluate the continued follow-up of these transfer 
patients. 
Infant follow-up may also have occurred at different facility, but little attempt is made to 
capture this data. It is plausible that women attend Bwaila ANC in order to give birth at Bwaila 
since it is a large district hospital, but they receive cART and have their infants tested at other 
clinics. Efforts to routinely capture this data are essential to determining whether the association 
between maternal retention in care and infant return implies a catastrophic, undocumented failure 
of PMTCT efforts within the group that is not retained in care. Interventions focused on retaining 
mothers and infants at a single institution are crucial to evaluating PMTCT efficacy. 
Linking records presented a significant challenge. Each HTC record was linked by hand 
to the corresponding ART mastercard and Early Infant Detection record. No consistent unique 
identifier was present across all three sources, so linkage was made on the basis of the mothers’ 
names. As HTC records are handwritten, name clarity and spelling varied throughout. The 
records identified as linked in this study were matched with a high degree of confidence. 
However, other records may have been created for the same woman but could not be linked with 
confidence. EMRS data entry issues also may have contributed to linkage difficulties. Data 
abstraction in real-time could reduce some of the errors resulting from retrospective review. A 
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total of 655 women have records of initiating cART under Option B+ in Lilongwe during the 
relevant time period, but 165 of these women did not have corresponding HTC records at Bwaila 
ANC. Some of these women may have tested HIV-positive previously but were not on cART at 
presentation. In addition, 88 women with HTC records were not linked an ART mastercard. 
Women who underwent HTC with a partner and learned that they were discordant were 
more likely to be retained with full adherence for three months than women who underwent 
individual HTC. Indeed, there was a trend towards women in discordant couples being initiated, 
having their first follow-up visit, and exhibiting three-month adherence. This may be the result of 
partner support. Understanding of treatment as prevention could also contribute to this trend[15]. 
More research is needed to clarify causal factors. This finding indicates that interventions to 
bring partners to HTC could help with overall retention. 
Women who underwent HTC with a partner and learned that they were concordant were 
less likely to initiate cART. This finding contradicts previous research on this topic[16-18]. One 
possible hypothesis is that these women may have been tested previously, and merely brought 
their partners for disclosure of their own status and testing of the partner’s status so that both 
could openly begin cART if indicated. The fact that women who underwent HTC as a 
concordant couple had 3.24 times the odds of women who underwent individual HTC to have a 
first follow-up visit supports this hypothesis. These women may also have been in care 
elsewhere. 
A significant proportion of women are lost to follow up along each step of the continuum 
of care. In light of this finding, interventions to help transition women between subsequent steps 
are urgently needed. Various studied interventions have the potential to reduce loss to follow up 
at each point in the continuum[19-22]. Additionally, interventions are needed to encourage 
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mothers to bring their infants back for testing at six weeks. Engaging women in a return to the 
healthcare facility may also serve to improve their cART retention. Each step in the continuum 
of care provides an opportunity for a targeted intervention, and further studies are needed to 
discern the most effective techniques for each step. 
Reducing vertical transmission of HIV offers the promise of a lower burden of disease on 
a population level. Developing nations with high HIV prevalence, such as Malawi, tend to 
emphasize caring for individuals with HIV over environmental protection. This societal strain 
has been shown to increase demand for resources controlled by women, including firewood, 
water, and medicinal plants[23]. As compared to PMTCT approaches focused solely on infant 
treatment, Option B+ offers more immediate potential to remedy the environmental damage 
resulting from societal focus on combating HIV because this approach begins by ensuring 
maternal health. This in combination with the demonstrated efficacy of Option B+ in preventing 
vertical transmission provides a strong basis for continuing to optimize this protocol in order to 
facilitate the widespread scale-up of an even more effective version of the program.   
 The population growth rate in Malawi ranks among the highest in the world at 2.8% per 
year[24]. This explosive growth places a considerable energy burden on a nation that has already 
endured rampant deforestation[24]. Malawi also faces endemic malaria and schistosomiasis, 
among other infectious vector-borne diseases and zoonoses, and the landscape changes required 
to support population growth have the potential to increase human exposure to these 
diseases[25]. Additionally, the 65% of Malawians who live below the national poverty line are at 
increased risk of susceptibility to natural disasters and man-made pollution[24]. Without spacing 
and limiting births, the issues associated with rapid population growth will continue to intensify 
in coming years. Family planning constitutes a major aim of PMTCT, and these programs have 
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the potential to increase access to the resources required to control population growth[13]. 
Effective scale-up of PMTCT will reduce both the risk of MTCT among HIV-infected women 
and the pressure facing Malawi as a result of rapid population expansion. This would ultimately 
reduce the number of women incorporated into future Option B+ cohorts, thereby minimizing the 
resources required for PMTCT efforts. 
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Conclusion 
Although Option B+ has been very effective at PMTCT, further interventions are 
required to ensure optimal protection of infants. There appears to be a group of mothers who are 
retained with full adherence and who return for infant testing, and transmission rates are 
extremely low among these individuals. However, this finding implies the existence of a non-
compliant group of mothers whose infants go untested. Interventions along the continuum of care 
are needed to ensure optimal PMTCT. Current efforts appear to have succeeded in educating 
discordant couples about the importance of cART, so there is much hope that new interventions 
will be able to prevent HIV transmission with even greater efficacy. Achieving PMTCT goals 
also includes increasing maternal access to family planning resources, and this has the potential 
to yield enormous environmental benefit in light of Malawi’s explosive population growth. 
Further investigations designed to optimize PMTCT protocols and evaluate the efficacy of 
existing programs within sub-Saharan Africa therefore serve a dual purpose of reducing the 
burden of disease and minimizing the strain placed on the fragile environments of developing 
nations.  
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 Table 1. Female Baseline Characteristics 
  
Total (N=578) 
    N (%) 
HTC Category*   
 Individual HTC 512 89% 
 Concordant cHTC  34 6% 
 Discordant cHTC  26 5% 
Last HIV Test 
  
 
Never 120 21% 
 
Negative 325 56% 
 
Positive 133 23% 
Time Since Last HIV Test 
  
 
Never Tested 120 21% 
 
<24 months 169 29% 
 
12-24 months 252 44% 
 
>24 months 37 6% 
Age (#)   
 15-20 94 16% 
 20-25 179 31% 
 25-30 180 31% 
 >30 125 22% 
 Mean 26.2±0.2 
Client Risk  
  
 
Low or Ongoing 552 96% 
 
High Last 3 Mo. 26 5% 
Partner HIV Status 
  
 
No Partner 12 2% 
 
Unknown 269 46% 
 
Negative 190 33% 
 
Positive 98 17% 
 
Missing 10 2% 
 
Table 1 shows female characteristics recorded in the HTC records during a visit to Bwaila ANC. 
*Covariate totals may not add up to the total study population due to missing data.  
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Table 2. Factors Associated with the Presence of a cART Record among All HIV-Positive 
Women 
  
cART Record Present (N=578) 
   
Unadjusted Adjusted 
    N (%) OR (95% CI) OR (95% CI) 
HTC Category* 
     
 
Individual HTC 512 (89%) 1 
 
1 
 
 
Concordant cHTC  34 (6%) 0.41 (0.19, 0.88) 0.48 (0.21, 1.08) 
 
Discordant cHTC  26 (5%) 0.93 (0.31, 2.77) 1.23 (0.38, 4.01) 
Last HIV Test 
     
 
Never 120 (21%) 1 
 
1 
 
 
Negative 325 (56%) 0.97 (0.54, 1.74) 1.48 (0.44, 4.96) 
 
Positive 133 (23%) 1.00 (0.50, 1.99) 1.45 (0.43, 4.86) 
Time Since Last HIV Test 
     
 
Never Tested 120 (21%) 1 
 
1 
 
 
<24 months 169 (29%) 0.61 (0.33, 1.13) 0.43 (0.14, 1.32) 
 
> 24 months 252 (44%) 1.41 (0.75, 2.67) 0.95 (0.30, 2.94) 
 
Unknown 37 (6%) 1.46 (0.46, 4.61) 1.46 (0.45, 4.73) 
Age 
     
 
15-20 94 (16%) 1 
 
1 
 
 
20-25 179 (31%) 0.80 (0.41, 1.59) 0.79 (0.38, 1.62) 
 
25-30 180 (31%) 1.40 (0.67, 2.92) 1.32 (0.61, 2.87) 
 
>30 125 (22%) 0.82 (0.39, 1.70) 0.76 (0.35, 1.63) 
Risk 
     
 
Other 552 (96%) 1 
 
1 
 
 
High 26 (4%) 0.58 (0.23, 1.49) 0.63 (0.22, 1.79) 
 
Table 2 shows the association of different covariates with the presence of a cART record within 
the entire study sample. *Covariate totals may not add up to the total study population due to 
missing data.  
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Table 3. Factors Associated with Having At Least One Follow-Up Visit among Women with 
a cART Record Present 
  
At Least 1 Follow-Up Visit Among Women with a cART 
Record Present (N=490) 
   
Unadjusted Fully Adjusted 
    N(%) OR (95% CI) OR (95% CI) 
HTC Category* 
     
 
Individual HTC 438 (90%) 1 
 
1 
 
 
Concordant cHTC 24 (5%) 2.69 (0.62, 11.65) 3.24 (0.73, 14.47) 
 
Discordant cHTC 22 (5%) 1.10 (0.36, 3.33) 1.53 (0.45, 5.13) 
Last HIV Test 
     
 
Never 102 (21%) 1 
 
1 
 
 
Negative 275 (56%) 1.53 (0.88, 2.67) 1.57 (0.53, 4.62) 
 
Positive 113 (23%) 1.27 (0.66, 2.44) 1.22 (0.43, 3.49) 
Time Since Last HIV Test 
     
 
Never Tested 102 (21%) 1 
 
1 
 
 
<24 months 131 (27%) 1.13 (0.61, 2.10) 0.74 (0.27, 2.05) 
 
> 24 months 224 (46%) 1.72 (0.96, 3.09) 1.13 (0.41, 3.07) 
 
Unknown 33 (7%) 1.38 (0.51, 3.75) 1.36 (0.49, 3.76) 
Age 
      
 
15-20 80 (16%) 1 
 
1 
 
 
20-25 147 (30%) 0.77 (0.40, 1.50) 0.76 (0.38, 1.53) 
 
25-30 160 (33%) 1.86 (0.90, 3.84) 1.91 (0.89, 4.11) 
 
>30 103 (21%) 0.98 (0.47, 2.02) 1.04 (0.48, 2.22) 
Risk 
      
 
Other 470 (96%) 1 
 
1 
 
 
High 20 (4%) 0.68 (0.24, 1.93) 0.51 (0.16, 1.64) 
 
Table 3 shows the association of different covariates with having at least one follow-up visit 
record among women with a record of initiating cART. *Covariate totals may not add up to the 
total study population due to missing data. 
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Table 4. Factors Associated with Retention in Care with Full Adherence for Three Months 
among Women With At Least One Follow-Up Visit 
  
Retained and Adherent after 3 Months of Follow-Up Among 
Women with At Least One Follow-Up Visit (N=398) 
   
Unadjusted Fully Adjusted 
    N(%) OR (95% CI) OR (95% CI) 
HTC Category* 
     
 
Individual HTC 352 (90%) 1 
 
1 
 
 
Concordant cHTC 22 (6%) 1.31 (0.55, 3.12) 1.42 (0.58, 3.50) 
 
Discordant cHTC 18 (4%) 2.85 (0.99, 8.16) 3.08 (1.02, 9.30) 
Last HIV Test 
     
 
Never 78 (20%) 1 
 
1 
 
 
Negative 229 (58%) 0.85 (0.51, 1.42) 0.61 (0.23, 1.60) 
 
Positive 91 (23%) 0.88 (0.48, 1.62) 0.64 (0.25, 1.68) 
Time Since Last HIV Test 
     
 
Never Tested 78 (20%) 1 
 
1 
 
 
<24 months 103 (26%) 0.65 (0.36, 1.17) 0.97 (0.39, 2.41) 
 
> 24 months 190 (48%) 1.02 (0.60, 1.74) 1.68 (0.70, 4.03) 
 
Unknown 27 (7%) 0.72 (0.30, 1.74) 0.62 (0.25, 1.58) 
Age 
      
 
15-20 64 (16%) 1 
 
1 
 
 
20-25 111 (28%) 0.9 (0.48, 1.66) 1.02 (0.53, 1.98) 
 
25-30 141 (35%) 1.40 (0.78, 2.54) 1.56 (0.82, 2.95) 
 
>30 82 (21%) 1.08 (0.56, 2.08) 1.16 (0.58, 2.32) 
Risk 
      
 
Other 383 (96%) 1 
 
1 
 
 
High 15 (4%) 1.56 (0.54, 4.46) 1.26 (0.39, 4.02) 
 
Table 4 shows the association of different covariates with retention in care with full adherence 
after three months of follow-up among women with at least one follow-up visit. *Covariate totals 
may not add up to the total study population due to missing data. 
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Table 5. Covariates Associated with the Presence of an Infant PCR Testing Record among 
All HIV-Positive Women 
  
Infant Record Present (N=578) 
   
Unadjusted Fully Adjusted 
  
N (%) OR (95% CI) OR (95% CI) 
HTC Category* 
     
 
Individual HTC 512 (89%) 1 
 
1 
 
 
Concordant cHTC 34 (6%) 1.12 (0.55, 2.27) 1.23 (0.57, 2.65) 
 
Discordant cHTC 26 (5%) 0.59 (0.24, 1.43) 0.51 (0.19, 1.34) 
Last HIV Test 
     
 
Never 120 (21%) 1 
 
1 
 
 
Negative 325 (56%) 1.40 (0.90, 2.18) 1.22 (0.52, 2.88) 
 
Positive 133 (23%) 1.06 (0.63, 1.78) 0.84 (0.36, 2.00) 
Time Since Last HIV Test 
     
 
Never Tested 120 (21%) 
  
1 
 
 
<24 months 169 (29%) 0.96 (0.59, 1.59) 0.92 (0.41, 2.07) 
 
> 24 months 252 (44%) 1.60 (1.02, 2.52) 1.24 (0.57, 2.69) 
 
Unknown 37 (6%) 1.08 (0.50, 2.35) 1.01 (0.44, 2.32) 
Age 
     
 
15-20 94 (16%) 1 
 
1 
 
 
20-25 179 (31%) 0.98 (0.58, 1.66) 1.12 (0.63, 1.99) 
 
25-30 180 (31%) 1.35 (0.80, 2.27) 1.19 (0.67, 2.12) 
 
>30 125 (22%) 1.47 (0.85, 2.57) 1.64 (0.89, 3.02) 
Risk 
     
 
Other 552 (96%) 1 
 
1 
 
 
High 26 (4%) 0.86 (0.37, 1.95) 1.18 (0.45, 3.09) 
Maternal Continuum of Care 
     
 
Retained and adherent for 3 mos. 197 (34%) 1 
 
1 
 
 
Follow-up but not adherent at 3 mos. 201 (35%) 0.56 (0.37, 0.83) 0.56 (0.37, 0.84) 
 
Linked but no follow-up 92 (16%) 0.19 (0.11, 0.35) 0.20 (0.11, 0.36) 
 
Not linked 88 (15%) 0.19 (0.10, 0.34) 0.19 (0.10, 0.35) 
 
Table 5 shows the association of different covariates with the presence of an infant PCR test 
record within the entire study sample. *Covariate totals may not add up to the total study 
population due to missing data. 
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Figure 1. Kaplan-Meier Survival Curve Showing Retention in Care among All HIV-
Positive Women Who Initiated cART 
 
 
Figure 1 depicts the Kaplan-Meier survival curve showing retention in care for all women in the 
study. Women at risk after a given length of retention in care is defined as the number of women 
still recorded to be in care at that point. This graph reflects all abstracted follow-up data. 
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